Myriad Genetics, Inc. (MYGN) Tops Q1 EPS by 2c; Raises FY

May 1, 2012 4:15 PM EDT
Myriad Genetics, Inc. (NASDAQ: MYGN) reported Q1 EPS of $0.34, $0.02 better than the analyst estimate of $0.32. Revenue for the quarter came in at $129.8 million versus the consensus estimate of $119.2 million.

Myriad Genetics, Inc. raises FY, sees FY2012 revenue of $492-$496 million, versus the consensus of $474 million.

For earnings history and earnings-related data on Myriad Genetics, Inc. (MYGN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment